Non classé

SPARTHA MEDICAL IS PART OF THE FIRST ORGAN-ON-CHIP INDUSTRY IN FRANCE. Structured by the BioValley France network in order to support and accelerate the emergence of innovative technologies, the network brings together major pharmaceutical and dermo-cosmetic industrial groups as well as research … Read More

Spartha Medical launched a Fundraising Campain in October 2020 … Read More

For next generation active intranasal asymmetric balloons with antibacterial and pro-healing properties … Read More

SPARTHA Medical’s participation in the 5th « Healthcare & Life Science & Entrepreneurship Workshop » SPARTHA Medical participated on September 3rd and 4th at the 5th « Healthcare & Life Science & Entrepreneurship Workshop » in the University of Pisa in Italy. The main … Read More

SPARTHA Medical: At war against microbes and viruses Here is a new article on SPARTHA Medical in Point éco Alsace by the CCI. This article traces the evolution of the company’s activities. The start-up is developing antimicrobial coatings to fight infections … Read More

Anti-SARS-CoV-2 coating project to protect hospital teams Explanation of our new anti SARS-CoV-2 project by our CSO.  SPARTHA Medical is working on the development of antiviral coatings, applicable on the surface of medical devices, various surfaces and even eventually on … Read More

Polyarginine Decorated Polydopamine Nanoparticles With Antimicrobial Properties for Functionalization of Hydrogels A new research article from Spartha in collaboration with INSERM U1121 and University of Strasbourg. The article describes the delivery of our technology in nanoparticle format, which enables its … Read More

Polyanionic Hydrogels as Reservoirs for Polycationic Antibiotic Substitutes Providing Prolonged Antibacterial Activity A recent article on one of our hydrogel based formulations and their use in combination with woundcare products against multiple infections. In collaboration with INSERM UMR 1121. Implantation … Read More

Personalization of medical device interfaces: decreasing implant-related complications by modular coatings and immunoprofiling A new editorial in Future Science Open Access Journal from our CEO and CSO. Personalized medicine currently plays a major role in reducing complications following surgery involving … Read More

SPARTHA MEDICAL HAS BEEN SELECTED FOR NETVA PROGRAMME 2020 SPARTHA Medical is one of the 14 Laureates of NETVA  2020 North America DeepTech programme organised by French Ministry of Foreign Affairs.As a part of the programme SPARTHA Medical will have … Read More

TERMINANION: SPARTHA Medical was granted a collaborative project by ANR(French National research agency). SPARTHA Medical with 2 INSERM units(INSERM 110 and 1121) will develop sprayable anti-viral coatings agains SARS-COV-2. Read more

Click the link … Read More

local biotechnology cluster with strong international links … Read More

SPARTHA attended T.T.T.I. 2020 … Read More

The CARNOT network : Research for business innovation. … Read More

selected as one of hellotmrc’s Deep Tech Pioneers! … Read More

SPARTHA Medical presentation in the official magazine of University of Strasbourg « @Savoir(s) » https://savoirs.unistra.fr/vivre-ensemble/generation-start-up/start-up-en-maceration-collective/ SPARTHA Medical is thrived to contribute to academic projects, as it makes its DNA. Click here to know more about us.  

SPARTHA Medical has been selected for the Invest Horizon Accelerator program (https://investhorizon.eu/). The accelerator supports Deep Tech companies for their Serie A investments from 2.5 Million Euros. InvestHorizon